What are the prevention options available after a positive genetic test for hereditary ovarian cancer?

After receiving a positive genetic test result indicating an inherited gene mutation that increases the risk of hereditary ovarian cancer, several prevention and risk management options are available. These include enhanced surveillance, risk-reducing preventive surgery, and medication that may help lower the likelihood of developing cancer. The most appropriate approach depends on individual factors and thorough discussion with a specialized physician.

Enhanced Surveillance and Periodic Screenings

For women with inherited gene mutations in genes such as BRCA1 or BRCA2, which significantly elevate the risk of ovarian cancer, an enhanced surveillance program may be recommended. However, it is important to know that there are currently no effective screening methods for ovarian cancer proven to detect tumors early enough to improve long-term survival [2]. In the past, some doctors recommended transvaginal ultrasounds and CA-125 blood tests, but these methods have not proven effective in early detection that leads to improved outcomes [2]. Therefore, enhanced surveillance is often of limited utility in the early detection of ovarian cancer.

Risk-Reducing Preventive Surgery

Preventive surgery, sometimes referred to as prophylactic or risk-reducing surgery, is an effective option for significantly reducing the risk of developing hereditary ovarian cancer. This surgery typically involves the removal of both ovaries and fallopian tubes (risk-reducing salpingo-oophorectomy). This procedure is particularly recommended for women carrying BRCA1 or BRCA2 gene mutations, as it can significantly reduce the risk of ovarian cancer, which also encompasses fallopian tube cancer and primary peritoneal cancer [2]. The timing of this procedure should be discussed with a doctor, taking into account factors such as age, desire for fertility, and the potential risks and benefits.

Risk-Reducing Medications

In addition to surgery, there may be medication options available to help reduce the risk of hereditary ovarian cancer. For example, oral contraceptives may reduce the risk of developing ovarian cancer [1]. However, the use of preventive medications must be carefully evaluated by a physician, considering the patient's full medical history and the potential risks and side effects of these medications. Research is ongoing to determine the best pharmacological strategies for preventing hereditary ovarian cancer.

Individual Considerations and Clinical Follow-up

The decision to pursue any of these preventive measures is highly personal and requires specialized medical advice. Individuals with positive genetic test results should discuss all available options with their healthcare team, which may include an oncologist, a geneticist, and a genetic counselor. This discussion will help in understanding the risks and benefits of each option, while taking into account individual health circumstances, family history, and personal preferences. More information on this topic can be obtained by visiting Hereditary Ovarian Cancer: Genetic Testing and Prevention (Arabic).

Medical references

• Ovarian Cancer
• BRCA Gene Changes: Cancer Risk and Genetic Testing
• 3 types of ovarian cancer, explained